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Identity 
Other names: Paired box homeotic gene 9 











341 amino acids; 36.3 kDa. 
Expression 
PAX9 is expressed in developing somites, specifically 
in the posterior ventrolateral region. These cells 
undergo an epithelial-mesenchymal transition, gaining 
increased motile capability as a consequence. 
Subsequent migration of this population generates the 
lateral sclerotome, which in turn gives rise to the ribs 
and neural arches. PAX9 contains a DNA binding 
paired domain, an octapeptide region and a carboxyl-





PAX9 is a transcription factor that regulates the 
expression of genes involved in mediating cell 
proliferation, resistance to apoptosis, and cell 
migration. Mice homozygous for Pax9 mutations die 
shortly after birth, lacking the thymus, parathyroid 
glands and ultimobranchial bodies derived from the 
third and fourth pharangeal pouches, presenting 
aberrant head and visceral skeleton development and a 
complete absence of teeth. 
Homology 
PAX9 shares homology through the conserved paired 
box domain with the other members of the nine strong 
PAX gene family. 
Mutations 
Germinal 




Caused by missense and frameshift PAX9 mutations. 




In humans, a reduction in expression levels of Pax9, 
together with those of the related Pax1 gene, have been 
reported in vertebral column chondrocytes of autopsied 
foeti presenting Jarcho-Levin syndrome,  
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a segmentation anomaly affecting thoracic and 
vertebral skeletal development. This syndrome shares 
similarities with the phenotype of the Pax9/Pax1 
double mutant mouse. 
Oesophageal invasive carcinoma and 
epithelial dysplasia. 
Disease 
PAX9 expression levels are significantly reduced in 
oesophageal invasive carcinoma and epithelial 
dysplasias compared to levels in normal tissue. There is 
a correlation between decreasing PAX9 expression and 
increased malignancy of the cancer. 
Prognosis 
Elevated PAX9 expression may be a useful prognostic 
marker indicative of favourable outcome in patients 
presenting oesophageal invasive carcinoma. 
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